bpc-157 decreases cox-2 High-level overview of pathways modulated by BPC-157. It is important BPC-157 might be one of
Description
At 1.0mg per week, 5 weeks
(FDA KPV listing) MOTS-c (obesity / osteoporosis) MOTS-c is listed for obesity and osteoporosistwo indications where approved peptide drugs exist (e.g., GLP-1s for obesity) but where the research-peptide ecosystem is still trying to invent shortcuts
Individual Variability: Not every supplement works for every person
It can also cause anxiety, a tingling sensation in your feet or hands, trouble sleeping, and constipation 2
